Access cutting-edge hepatocellular carcinoma (hcc) treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Palo Alto location
Preparing your pre-screening questions…
Access hepatocellular carcinoma (hcc) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatocellular carcinoma (hcc) treatment provided free
Check if you qualify for this hepatocellular carcinoma (hcc) clinical trial in Palo Alto, CA
No-Cost Study Care
Local to Palo Alto
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to determine if baseline liquid biopsy assays (CTC and cf-DNA) as well as single circulating tumor cell-DNA (sCTC DNA) dynamics in the early post-treatment period can predict subsequent treatment response to Y-90 radioembolization in patients with hepatocellular carcinoma (HCC).
Sponsor: Palo Alto Veterans Institute for Research
Yes, this clinical trial (NCT07303712) has an active research site in Palo Alto, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hepatocellular carcinoma (hcc) treatment options in Palo Alto, CA, this clinical trial (NCT07303712) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatocellular carcinoma (hcc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hepatocellular carcinoma (hcc) clinical trials near you to find additional studies recruiting in your area.
See all liver cancer clinical trials recruiting in Palo Alto — not just this study.
Browse Liver Cancer Trials in Palo Alto →